Work

Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer

Year: 2022

Type: article

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2022.08.005

Authors: Zeynep B. Zengin, Sumanta K. Pal, David F. McDermott, Bernard Escudier, Thomas E. Hutson, Camillo Porta, Elena Verzoni, Michael B. Atkins, Vijay Kasturi, Brian Rini

Institutions: City Of Hope National Medical Center, City of Hope, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Institut Gustave Roussy, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Fondazione IRCCS Istituto Nazionale dei Tumori, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, AVEO Oncology (United States), Vanderbilt-Ingram Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4292822476

FWCI: 0.843

Cites: 12

Cited by: 6

Related to: 10